Efficacy and safety of Cadonilimab in the treatment of recurrent/metastatic and advanced cervical cancer: a systematic review and meta-analysis

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-01-12
DOI
https://doi.org/10.3389/fimmu.2025.1729380
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of Cadonilimab in the treatment of recurrent/metastatic and advanced cervical cancer: a systematic review and meta-analysis

Yan Liu, Qiuqi Zhuang
Frontiers in Immunology
Endometrial and Cervical Cancer Treatments
article

Efficacy and safety of Cadonilimab in the treatment of recurrent/metastatic and advanced cervical cancer: a systematic review and meta-analysis

Yan Liu, Qiuqi Zhuang
article en

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 16
Fujian University of Traditional Chinese Medicine (CN)
Good health and well-being
Openalex Percentile: Top 91%
Endometrial and Cervical Cancer Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and safety of Cadonilimab in the treatment of recurrent/metastatic and advanced cervical cancer: a systematic review and meta-analysis — Yan Liu, Qiuqi Zhuang · Frontiers in Immunology (2026) | TGRS Research Map | TGRS